'Vampire' Bacteria Has Potential as Living Antibiotic
A vampire-like bacteria that leeches onto specific other bacteria - including certain human pathogens - has the potential to serve as a living antibiotic for a range of infectious diseases, a new study indicates.
Read more ...
Colorectal cancer drug may cause permanent nerve damage
Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.
Read more ...
Genetically modified 'serial killer' T cells obliterate tumors in leukemia patients
In a cancer treatment breakthrough 20 years in the making, researchers from the University of Pennsylvania's Abramson Cancer Center and Perelman School of Medicine have shown sustained remissions of up to a year among a small group of advanced chronic lymphocytic leukemia (CLL) patients treated with genetically engineered versions of their own T cells.
Read more ...
CONTRACT's Questionnaire to Analyse and Improve Informed Consent in Clinical Trials
In the frame of the European Project CONTRACT, which aims at analysing, improving and harmonising "informed consent" across Europe a questionnaire has been set up which will analyse the current situation concerning the legal, ethical, technical and clinical handling of consent, mainly in European projects dealing with vulnerable patient groups.
Read more ...
IMI announces a new total of 23 unique projects to boost drug innovation
The Innovative Medicines Initiative (IMI), currently the largest public-private partnership in the biopharmaceutical sector, launches its second wave of research projects which address key areas including cancer, immune-mediated diseases, infectious disorders and electronic health.
Read more ...
Which Pharma Product Websites are Driving Consumers to the Doctor to Request Prescriptions?
Pharmaceutical and healthcare market research company Manhattan Research recently released the ePharma Consumer® v10.0 study, which explores the online behaviors of ePharma Consumers, or U.S. consumers using the Internet for prescription drug information.
Read more ...
IMS Health Forecasts Global Pharmaceutical Market Growth of 5-7 Percent in 2011, Reaching $880 Billion
The value of the global pharmaceutical market is expected to grow 5-7 percent in 2011, to US$880 billion, compared with a 4-5 percent pace this year, according to IMS Health. The forecast, included in the latest release of IMS Market Prognosis™, is the leading annual industry indicator of market dynamics and therapy performance.
Read more ...
Pharmaceutical and healthcare market research company Manhattan Research recently released the ePharma Consumer® v10.0 study, which explores the online behaviors of ePharma Consumers, or U.S. consumers using the Internet for prescription drug information. 